Skip to main content

Chemical Modeling with p-Boronophenylalanine for Boron Accumulation to and Release from Melanoma

  • Chapter
Book cover Cancer Neutron Capture Therapy

Abstract

This paper describes a proposed mechanism of boron accumulation to and release from melanoma after administration of p-Boronophenylalanine (p-BPA) to melanoma patients. The study is based on chemical experiments modeling the phenomena occurring in melanoma cells. Before the mechanism study, we would like to mention the history of the BNCT compound, p-BPA.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. A. H. Soloway, R. L. Wright, and J. R. Messer, Evaluation of boron compounds for use in neutron capture therapy of brain tumors. 1. Animal investigations. J. Pharniacol. Exp. Ther, 134: 117–122, 1961.

    CAS  Google Scholar 

  2. Y. Mishima, Neutron capture treatment of malignant melanoma using 1°B-chlorpromazine compound. in: “Pigment Cell. Vol. 1:Mechanisms in pigmentation ”, V. J. Mc. Govern and P. Russell eds., S. Karger, Basel, 1973, pp. 215–221.

    Google Scholar 

  3. K. Yoshino, H. Kakihana, M. Okamoto, and Y. Mori, Chemical behavior of Dopaborate and10B-p-Boronophenylalanine. in: “Neutron Capture Therapy” H. Hatanaka. ed., Nishimura Co., Ltd., Niigata, Japan, 1986, pp. 55–60.

    Google Scholar 

  4. H. Kakihana, M. Okamoto and K. Yoshino, Chemical problems in neutron capture therapy. Kyoto Univ. Research Reactor Inst. Technical Report - 195: 115–120, 1980. (in Japanese)

    Google Scholar 

  5. Y. Mishima, M. Ichihashi, T. Nakanishi, T. Nakagawa, Selective neutron capture therapy of cancer cells using their specific functional differentiation. -with special reference to malignant melanoma- Kyoto Univ. Research Reactor Inst. Technical Report - 195: 3–18, 1980.

    Google Scholar 

  6. M. Ichihashi, T. Nakanishi, and Y. Mishima, Specific killing effect of 10B1-para-boronophenylalanine in thermal neutron capture therapy of malignant melanoma: in vitro radiobiological evaluation. J. Invest. Dermatol., 78: 215–218, 1982.

    Article  PubMed  CAS  Google Scholar 

  7. K. Yoshino, M. Okamoto, H. Kakihana, Y. Mori, Y. Mishima, M. Ichihashi, M. Tsuji, and T. Nakanishi, Chemical assay of boron and its distribution in melanoma-bearing subjects. in: “Neutron Capture Therapy ”, H. Hatanaka ed., Nishimura Co. Ltd., Niigata, Japan, 1986, pp. 291–302.

    Google Scholar 

  8. Y. Mishima, M. Ichihashi, T. Nakanishi, M. Tsuji, M. Ueda, T. Nakagawa, and T. Suzuki, Cure of malignant melanoma by single thermal neutron capture treatment using melanoma seeking compounds; 10B/melanogenesis interaction to in vitro/in vivo radiobiological analysis to preclinical studies. in: Proc. 1st Int. Symp. Neutron Capture Therapy, R. G. Fairchild, G. L. Brownell eds. BNL51730. BNL, Upton, N.Y. 1984, pp. 355–364.

    Google Scholar 

  9. Y. Mishima, M. Ichihashi, S. Hatta, C. Honda, K. Yamamura, T. Nakagawa, H. Obara, J. Shirakawa, J. Hiratsuka, K. Taniyama, C. Tanaka, K. Kanda, T. Kobayashi, T. Sato, M. R. Ishida, Y. Ujeno, M. Takahashi, M. Abe, T. Nozaki, O. Aizawa, T. Matsumoto, T. Sato, H. Karashima, K. Yoshino, and H. Fukuda, First human clinical trial of melanoma neutron capture. Diagnosis and therapy. Strahlenther Onkol. 165: 251–254, 1989.

    PubMed  CAS  Google Scholar 

  10. K. Yoshino, A. Suzuki, Y. Mori, H. Kakihana, C. Honda, Y. Mishima, T. Kobayashi, and K. Kanda, Improvement of solubility of p-Boronophenylalanine by complex formation with monosaccharides. Strahlenther. Onkol. 165: 127–129, 1989.

    PubMed  CAS  Google Scholar 

  11. Y. Mori, A. Suzuki, K. Yoshino, and H. Kakihana, Complex formation of p-Boronophenylalanine with some monosaccharides. Pigment Cell Research 2: 273–277, 1989.

    Article  PubMed  CAS  Google Scholar 

  12. Y. Kinoshita, K. Yoshino, Y. Mori, H. Kakihana, and Y. Mishima, Complex formation of phenylboronic acid derivatives with alodopentoses and oligosaccharides. in: “Progress in Neutron Capture Therapy for Cancer”, B. J. Allen et al. eds., Plenum Press, New York, 1992, pp. 243–246.

    Chapter  Google Scholar 

  13. H. Kakihana, K.. Yoshino, and Y. Mori, Relation between structures of p-Boronophenylalanine related compounds and their usefulness for boron neutron capture therapy. in: “Advances in Neutron Capture Therapy”, A. H. Soloway et al. eds., Plenum Press, New York, 1993, pp. 257–260.

    Chapter  Google Scholar 

  14. C. Honda, M. Shiono, N. Wadabayashi, S. Hatta, M. Ichihashi, Y. Mishima, K. Yoshino, T. Kobayashi, K. Kanda, and Y. Hori, 1081-BPA administration to human melanoma patients: boron analytical studies for neutron capture therapy. Kyoto Univ. Res. Reactor Inst. Technical Report - 357: 7–18, 1991.

    Google Scholar 

  15. H. Fukuda, BNCT of malignant melanoma - Radiobiological analysis and data comparison with conventional radiotherapy. “Cancer Neutron Capture Therapy”, Y. Mishima ed., Plenum Press, New York, Proc. 6th Intnl. Symp. on Neutron Capture Therapy for Cancer, Oct. 31 - Nov. 4, 1994, Kobe Japan.

    Google Scholar 

  16. S. Ueda, Y. Imahori, Y. Ohmori, K. Ono, T. Kobayashi, M. Takagaki, Y. Oda, T. Ido, and Y Mishima, Positron emission tomography and boron neutron capture therapy system to a patient with brain tumor. “Cancer Neutron Capture Therapy”, Y. Mishima ed., Plenum Press, New York, Proc. 6th Intnl. Symp. on Neutron Capture Therapy for Cancer, Oct. 31 - Nov. 4, 1994, Kobe Japan.

    Google Scholar 

  17. J. A. Coderre, BNCT for malignant glioma using BPA: Radiation biology and treatment planning. “Cancer Neutron Capture Therapy”, Y. Mishima ed., Plenum Press, New York, Proc. 6th Intnl. Symp. on Neutron Capture Therapy for Cancer, Oct. 31 - Nov. 4, 1994, Kobe Japan.

    Google Scholar 

  18. J. A. Coderre, J. D. Glass, R. G. Fairchild, U. Roy, S. Cohen, and I. Fand. Selective targeting of boronophenylalanine to melanoma in BALB/c mice for neutron capture therapy. Cancer Res. 47: 6377–6383, 1987.

    PubMed  CAS  Google Scholar 

  19. C. Honda, M. Shiono, N. Wadabayashi, M. Ichihashi, Y. Mishima, K. Yoshino, T. Kobayashi, K. Kanda, Y. Hori, and H. Karashima, Increased boron uptake by hamster melanoma using L-isomer10B1-BPA for neutron capture therapy. Kyoto Univ. Res. Reactor Inst. Technical Report - 356: 243–248, 1991.

    Google Scholar 

  20. J. A. Coderre, J. D. Glass, R. G. Fairchild, P. L. Micca, I. Fand, and D. D. Joel, Selective delivery of boron by the melanin precursor analogue p-boronophenylalanine to tumors other than melanoma. Cancer Res. 50: 138–141, 1990.

    PubMed  CAS  Google Scholar 

  21. Y. Mishima, A post melanoma era: Control of melanogenesis and melanoma growth. Pigment Cell Research Suppl. 2: 3–16, 1992.

    CAS  Google Scholar 

  22. M. Shiono, T. Shibata, M. Ichihashi, Y. Mishima, The mechanism of the selective affinity of 10B1 -paraboronophenylalanine for malignant melanoma.. J. Kobe Univ. School of Medicine 53 (1): 35–41, 1992.

    CAS  Google Scholar 

  23. We have confirmed by the UV spectroscopic method.

    Google Scholar 

  24. C. Honda, M. Shiono, N. Wadabayashi, M. Ichihashi, Y. Mishima, T. Kobayashi, K. Kanda, Y. Hori, and K. Yoshino, Increased selective 11B-uptake by malignant melanoma using systematic administration of 10B1 -BPA-fructose complex. in: “Progress in Neutron Capture Therapy for Cancer”. B. J. Allen et al. eds., Plenum Press, New York, 1992, pp. 421–424.

    Chapter  Google Scholar 

  25. H. Fukuda, J. Hiratsuka, C. Honda, T. Kobayashi, K. Yoshino, H. Karashima, J. Takahashi, Y. Abe, K.. Kanda, M. Ichihashi, and Y. Mishima, Boron neutron capture therapy of malignant melanoma using 10B-paraboronophenylalanine with special reference to evaluation of radiation dose and damage to the normal skin. Radiation Research 138: 435–442, 1994.

    Article  PubMed  CAS  Google Scholar 

  26. K. Yoshino, T. Maruyama, Y. Mori, H. Kakihana, and Y. Mishima, Capture ofp-Boronophenylalanine by melanin-related compounds: Complex formation of p-Boronophenylalanine with L-DOPA. in: “Advances in Neutron Capture Therapy”, A. H. Soloway et al. eds., Plenum Press, New York, 1993, pp. 249–252.

    Chapter  Google Scholar 

  27. K. Yoshino, H. Kakihana, and Y. Mori, N. Torii, H. Takahashi, and Y. Mishima, Proposed mechanism of capture and release ofp-Boronophenylalanine in melanoma cells: chemical behavior ofp-Boronophenylalanine-fructose complex in L-dopa solution. in: “Advances in Neutron Capture Therapy”, A. H. Soloway et al. eds., Plenum Press, New York, 1993, pp. 253–256.

    Chapter  Google Scholar 

  28. E. M. Rinchik, S. J. Bultman, B. Horsthemike, S. T. Lee, K. M. Strunk, R. A. Sparitz, K. M. Avidano, M. T. C. Jong, and R. D. Nicholls, A gene for the mouse pink-eyed dilution locus and lbr human type II oculocutaneous albinism. Nature, 361: 72–76. 7 January 1993.

    Google Scholar 

  29. K. T. Yasunobu and E. R. Norris, Mechanism of borate inhibition of diphenol oxidation by tyrosinase..1. Biol. Chem. 227:473–482, 19.57.

    Google Scholar 

  30. K. Yoshino, H. Takahashi, N, Torii, Y. Mori, and H. Kakihana, Complex formation of p-Boronophenylalanine with melanin precursor, Dopa, and its oxidation. Kyoto Univ. Res. Reactor Inst. Technical Report–382: 33–38, 1993. (in Japanese).

    Google Scholar 

  31. Y. Mishima, Molecular and biological control of melanogenesis through tyrosinase genes and intrinsic and extrinsic regulatory factors, Pigment Cell Res. 7: 376–387, 1994.

    Article  PubMed  CAS  Google Scholar 

  32. A. Wilczek and Y. Mishima, Regulatory factors for polymerization of melanin monomers within coated vesicles and premelanosomes in melanoma cells. Melanoma Res., 3: 255–262, 1993.

    PubMed  CAS  Google Scholar 

  33. S. Hatta, Y. Mishima, M. Ichihashi, and S. Ito, Melanin monomers within coated vesicles and premelanosomes in melanin synthesizing cells.. 1. Invest. Dermatol., 91: 181–184, 1988.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Springer Science+Business Media New York

About this chapter

Cite this chapter

Yoshino, K., Mori, Y., Kakihana, H., Takahashi, H., Mishima, Y., Ichihashi, M. (1996). Chemical Modeling with p-Boronophenylalanine for Boron Accumulation to and Release from Melanoma. In: Mishima, Y. (eds) Cancer Neutron Capture Therapy. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9567-7_9

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-9567-7_9

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4757-9569-1

  • Online ISBN: 978-1-4757-9567-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics